YOUNG JONATHAN

PrivateCIK: 1779805
Location

SOUTH SAN FRANCISCO, CA

YOUNG JONATHAN (EVP, Chief Operating Officer) exercised options at AKERO THERAPEUTICS, INC.

Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.

M · 3 exercises
InsiderYOUNG JONATHANCIK 1779805
IssuerAKERO THERAPEUTICS, INC.CIK 1744659
Officer· EVP, Chief Operating Officer
Since Jun 2019
-9.26K
Net shares
Net seller
$290.3K
Total acquired
0
Open market trades
0B · 0S
7
Total transactions
12.55K acquired · 21.81K disposed
Non-Derivative Transactions4

Common Stock

Direct
M · Option Exercise

Shares

+4.28K

Price / share

$21.09

Trade value

$90.35K

% of position

2.2%
11/24/2025
196.90K201.18K

Common Stock

Direct
M · Option Exercise

Shares

+3.53K

Price / share

$28.35

Trade value

$99.99K

% of position

1.8%
11/24/2025
201.18K204.71K

Common Stock

Direct
M · Option Exercise

Shares

+4.74K

Price / share

$21.10

Trade value

$99.99K

% of position

2.3%
11/24/2025
204.71K209.45K

Common Stock

Direct
G · Gift

Shares

9.26K

Price / share

Trade value

% of position

4.4%
11/26/2025
209.45K200.19K
Total

Net shares

+3.29K

Net value

$290.33K

Derivative Transactions3

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

4.28K shares

Shares

4.28K

Strike price

21.09

Held after

0.00

Exercisable

11/24/2025

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

3.53K shares

Shares

3.53K

Strike price

28.35

Held after

0.00

Exercisable

11/24/2025

Stock Option (Right to Buy)

Direct
M · Option Exercise
Converts to

Common Stock

4.74K shares

Shares

4.74K

Strike price

21.1

Held after

0.00

Exercisable

11/24/2025
Non-Derivative Holdings (Post-Transaction)3

Common Stock

Indirect
Shares owned20K

Common Stock

Indirect
Shares owned20K

Common Stock

Indirect
Shares owned20K
Total
60K indirect60K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
YOUNG JONATHAN — Insider Transaction (Form 4) Filed Nov 26, 2025 | Finecho